Table 2 Univariate analysis predicting necrosis at PC-RPLND
Necrosis | Teratoma orviable GCT | PValue | |
|---|---|---|---|
Components at orchiectomyhistology (%): | |||
Embryonal | 22.7 ± 30.1 | 32.9 ± 29.7 | 0.370 |
Yolk sac | 4.3 ± 11.5 | 4.1 ± 8.0 | 0.737 |
Teratoma | 12.7 ± 23.7 | 13.8 ± 17.1 | 0.502 |
Endodermal sinus | 1.7 ± 4.5 | 5.0 ± 11.7 | 0.628 |
Retroperitonial node size | |||
RP node cm before chemotherapy | 6.5 ± 4.1 | 6.1 ± 5.5 | 0.849 |
RP node cm after chemotherapy | 3.2 ± 1.8 | 5.3 ± 4.8 | 0.331 |
Relative change in RP node size | 31.9 ± 48.3 | 9.4 ± 38.8 | 0.044 |
Absolute change in RP node size | 3.2 ± 2.9 | 0.78 ± 2.9 | 0.053 |
Relative reduction in RP node | 56.4 ± 14.0 | 26.2 ± 20.1 | <0.001 |
Relative enlargement in RP node | 35.6 ± 44.1 | 60.1 ± 22.5 | 0.425 |
Serum markers | |||
hCG after chemotherapy | 0.0 | 0.0 | ** |
AFP after chemotherapy | 1.3 ± 0.4 | 22.1 ± 49.3 | <0.001 |
Relative change in AFP afterchemotherapy | 15.7 ± 46.7 | −83.7 ± 5.13 | 0.075 |
LDH after chemotherapy | 307.7 ± 60.7 | 324.0 ± 65.8 | 0.399 |
Relative change in LDH afterchemotherapy | 1.5 ± 15.9 | 0.68 ± 27.4 | 0.915 |